news

The new challenges of epidemic prevention and control in this round and suggestions from Medox

Since March this year, the number of local infected people has exceeded 70000, and there were more than 600 middle and high risk areas at one time. In particular, the outbreak of the epidemic in Shanghai, which is adjacent to our province, has made the prevention and control of the epidemic in China face serious challenges of complexity, difficulty, and repetition. Our province is facing a new and new examination of prevention and control. At present, the national epidemic is in a high-level plateau stage.


According to comprehensive newspaper information, the main manifestations of this epidemic are as follows:

1. Increased transmission rate

The current domestic epidemic seems to be mainly caused by the Omicron BA. 2 variant. This strain has a 30% higher infection rate than BA. 1, making it the most contagious upper respiratory virus in history. The possibility of human intervention for prevention and control is extremely low.

2. Limited isolation space

Once the infection grows rapidly, there will be a large number of cases in the short term. This is not about how powerful the virus is, but because of the large population base, the number obtained by multiplying the lowest mortality rate by a larger base is very large. Once a large-scale outbreak occurs, there is no longer enough space for isolation. Once medical personnel are infected on a large scale, the possibility of the medical system collapsing is extremely high. It is impossible to have enough shelters and isolation rooms for rapid large-scale infection, and it is estimated that on-site isolation will be the only option.

Normalization of epidemic prevention and control

In the context of the continuous spread of the global epidemic, it is impossible to completely end epidemic prevention and control in a short period of time. It is very likely to remain in a state of epidemic prevention and control for a long time, which is determined by the complexity, long-term nature, and difficulty of epidemic prevention and control. Therefore, epidemic prevention and control will be normalized.

 

Once the epidemic erupts rapidly, there may be a large number of patients requiring intravenous infusion and oxygen supplementation in the short term. We have also summarized a few things we can do before the outbreak of the epidemic:

1) Establish contingency plans as soon as possible to deal with large-scale infections and saturation of the healthcare system;

2) Strengthen community health services, volunteer and resident training, and provide guidance on home self inspection, isolation, self-care and treatment in the event of a rapid outbreak.




3) Vaccination (Sinovac) should be continuously strengthened.

4) Establish a community oxygen supplementation center and prepare oxygen production and supplementation equipment. Once the epidemic breaks out rapidly, supplementary services can be provided at community health stations when the medical system is fully staffed.




5) Families with elderly and underlying disease patients may consider preparing portable oxygen cylinders and household oxygen concentrators.




In setting up community oxygen centers, we can provide customers with safe, convenient, and intelligent products while balancing economy. Hangzhou Yiyang Health Technology Co., Ltd. is an international life technology group that integrates research and development, design, construction, sales, and operation. Since its establishment, we have always adhered to the business philosophy of "creating a healthy lifestyle home" and strategically laid out the entire oxygen related field. Our products include medical molecular sieve oxygen concentrators, household oxygen concentrators, and a series of oxygen producing products. We hope to contribute to the prevention and control of the epidemic in such a special situation.




 

Characteristics of Medox Products

The entire system is fully automated, with automatic pressure sensing and 24-hour monitoring of oxygen quality

On site oxygen production is safe and reliable, achieving continuous and uninterrupted supply of sufficient oxygen without being affected by procurement, requiring no manual handling, and not limited by usage time

Ensure the safe operation of medical molecular sieve oxygen production equipment and real-time monitoring of equipment operating parameters, equipped with PLC automatic control system and human-machine dialogue touch screen, which can grasp the working status of the equipment in real time

The equipment can automatically adjust the on and off operation of each unit according to the oxygen consumption of the hospital.





 

Welcome to contact: 0571-89168836

 


Recommend news
Tags

contact

Be the first to know about our new product launches, latest blog posts and more.
Hangzhou Medoxygen Technology Co., Ltd. (hereinafter referred to as Medox) is an international life technology group and national high-tech enterprise. The company integrates research, development, pr...

Any question or request?

Click below, we’ll be happy to assist. contact
Copyright © 2024. Hangzhou medoxygen Technology Co., LtdAll Rights reserved